Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of Diabetic Nephropathy

Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of Diabetic Nephropathy

Background: Diabetic nephropathy (DN) has been the major contributor to chronic kidney disease (CKD), end stage renal disease (ESRD), and cardiovascular risks. Incretin pathway modulators (GLP-1 analogs, GLP-1R agonist, GLP-1 secretagogues and DPP-IV inhibitors) and SGLT2 inhibitors are presently th...

Full description

Bibliographic Details
Main Authors: Anuj Kumar Borah, Semim Akhtar Ahmed, Jagat C. Borah
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Phytomedicine Plus
Subjects:
Diabetic nephropathy
GLP-1 secretagogues
DPP-IV inhibitors
SGLT2 inhibitors
Herbal medicine and incretin modulators
Online Access:http://www.sciencedirect.com/science/article/pii/S2667031322000112

Internet

http://www.sciencedirect.com/science/article/pii/S2667031322000112

Similar Items